"Ophthalmic Solutions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS.
| Descriptor ID |
D009883
|
| MeSH Number(s) |
D26.776.708.645 D27.505.954.578.645 D27.720.752.608
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ophthalmic Solutions".
Below are MeSH descriptors whose meaning is more specific than "Ophthalmic Solutions".
This graph shows the total number of publications written about "Ophthalmic Solutions" by people in this website by year, and whether "Ophthalmic Solutions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 3 | 3 |
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2009 | 2 | 2 | 4 |
| 2016 | 1 | 0 | 1 |
| 2020 | 0 | 2 | 2 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ophthalmic Solutions" by people in Profiles.
-
Fill levels, cost comparisons, and expulsion force requirements of commonly used topical ophthalmic steroids. J Cataract Refract Surg. 2022 Apr 01; 48(4):475-480.
-
Analysis of topical dosing and administration effects on ocular drug delivery in a human eyeball model using computational fluid dynamics. Comput Biol Med. 2022 02; 141:105016.
-
Netarsudil for the Treatment of Open-Angle Glaucoma and Ocular Hypertension: A Literature Review. Ann Pharmacother. 2021 08; 55(8):1025-1036.
-
Antimicrobial Peptides Derived from the Immune Defense Protein CAP37 Inhibit TLR4 Activation by S100A9. Invest Ophthalmol Vis Sci. 2020 04 09; 61(4):16.
-
A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res. 2016 12; 6(6):735-754.
-
N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patients. Am J Ther. 2009 Nov-Dec; 16(6):517-33.
-
Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones. Adv Ther. 2009 Apr; 26(4):447-54.
-
N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications. J Drug Target. 2009 Jan; 17(1):36-63.
-
State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases. Curr Clin Pharmacol. 2009 Jan; 4(1):4-37.
-
High-viscosity hydroxypropylmethylcellulose blunts postprandial glucose and insulin responses. Diabetes Care. 2007 May; 30(5):1039-43.